L 44-0
L44-0 is a nicotinic acid derivative. L44-0 reduces atherosclerotic lesions and decreases vascular norepinephrine levels in the renal arteries, femoral arteries, and veins in a New Zealand white rabbit model of atherosclerosis. L44-0 can be used in research on cardiovascular and cerebrovascular diseases such as atherosclerosis[1].
Product Specifications
CAS Number
[95240-93-0]
UNSPSC
12352005
Target
Others
Related Pathways
Others
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Smiles
O=C(OC1=CC=C(C=C1C(C)(C)C)C2CCCCC2)C3=C[N+]([O-])=CC=C3
Molecular Formula
C22H27NO3
Molecular Weight
353.45
References & Citations
[1]Teixeira F, et al. Experimental atherogenesis and vascular noradrenaline content in NZW rabbits and activity of a new nicotinic acid derivative (L 44-0) . J Lipid Mediat.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
